J.M. Melotek

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors

Jason J. Luke, Jeffrey M. Lemons, Theodore Karrison et al. · Journal of Clinical Oncology · 2018 · 574 citations

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

Tanguy Y. Seiwert, Corey C. Foster, Elizabeth A. Blair et al. · Annals of Oncology · 2018 · 220 citations · Full text

A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study

Christine M. Bestvina, Kelli B. Pointer, Theodore Karrison et al. · Journal of Thoracic Oncology · 2021 · 122 citations

Adaptive Radiotherapy, Radiation Medicine, Radiation Therapy +8

Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer

Victoria Villaflor, J.M. Melotek, Theodore Karrison et al. · Annals of Oncology · 2016 · 95 citations

Advanced Head, Response-adapted Volume De-escalation, Neck Cancer +13

Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience

Corey C. Foster, J.M. Melotek, Ryan J. Brisson et al. · Oral Oncology · 2018 · 54 citations

Definitive Chemoradiation, Medicine, Oral Cavity +6